Innovating Works

Beactica

Desconocido
SciLifeLab PULSE: SciLifeLab Programme for fUture Leaders in life SciencE SciLifeLab PULSE is a MSCA-COFUND postdoctoral programme of excellence in Life Sciences coordinated by the Swedish research infrastructure S...
2024-09-16 - 2030-08-31 | Financiado
UBIMOTIF: Short linear interaction motifs as specificity determinants in the ubiquitin system discovery mec... BEACTICA THERAPEUTICS AB participó en un H2020 H2020-MSCA-ITN-2019 A major challenge is the lack of therapeutic approaches for numerous human diseases, which poses a societal challenge. The ubiquitin system...
2019-08-09 - 2024-05-31 | Financiado
EpiGlioT: Epigenetic Glioblastoma Therapeutics BEACTICA THERAPEUTICS AB tramitó un H2020 H2020-EIC-SMEInst-2018-2020 The goal of this project is to develop a successful treatment that combats the progression of glioblastoma and improve patients’ quality of...
2018-06-01 - 2018-09-30 | Financiado
FRAGNET: FRAGments training NETwork BEACTICA THERAPEUTICS AB participó en un H2020 H2020-MSCA-ITN-2015 The promise of more efficient lead discovery is fuelling the enthusiasm for fragment-based lead discovery (FBLD). In this approach, highly s...
2015-08-11 - 2020-02-29 | Financiado
ENABLE: European Gram Negative Antibacterial Engine BEACTICA THERAPEUTICS AB participó en un FP6 The intensive use and misuse of antibiotics has resulted in some level of antibiotic resistance in essentially all human bacterial pathogens...
2014-02-01 - 2020-01-31 | Financiado
SYNSYS: Synaptic Systems dissecting brain function in health and disease BEACTICA THERAPEUTICS AB participó en un FP7 Major disorders of the Central Nervous System (CNS) affect one in three people in the developed world, often seriously disable the affected...
Financiado
NEUROCYPRES: Neurotransmitter Cys loop receptors structure function and disease BEACTICA THERAPEUTICS AB participó en un FP7 Cys-loop receptors (CLRs) form a superfamily of structurally related neurotransmitter-gated ion channels, comprising nicotinic acetylcholine...
Financiado
BRAINTRAIN: BrainTrain Integrative neuroscience school on brain function and disease BEACTICA THERAPEUTICS AB participó en un FP7 Brain disorders, in particular neurodegenerative diseases and mental illnesses are among the most prevalent and debilitating diseases. Becau...
Financiado
ENABLE: European Gram Negative Antibacterial Engine BEACTICA THERAPEUTICS AB participó en un FP7 The intensive use and misuse of antibiotics has resulted in some level of antibiotic resistance in essentially all human bacterial pathogens...
Financiado
FLUCURE: Development of novel antiviral drugs against Influenza BEACTICA THERAPEUTICS AB participó en un FP7 Influenza viruses cause a highly contagious respiratory disease in both humans and animals. Typically, influenza spreads worldwide in season...
Financiado
FLUDRUGSTRATEGY: Combating influenza using a novel drug strategy BEACTICA THERAPEUTICS AB participó en un FP7 Objective: To find and produce novel target compounds against the influenza virus. Influenza A capsid protein is the target since it does no...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.